Related references
Note: Only part of the references are listed.An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure
Subramanian Boopathi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A resurrection of aducanumab for Alzheimer's disease
Lon Schneider
LANCET NEUROLOGY (2020)
Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways
Steven M. Greenberg et al.
NATURE REVIEWS NEUROLOGY (2020)
Staging of tau distribution by positron emission tomography may be useful in clinical staging of Alzheimer disease
Kenta Aohara et al.
NEUROLOGY AND CLINICAL NEUROSCIENCE (2020)
In vivo detection of tau fibrils and amyloid β aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy
Maria Calvo-Rodriguez et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways
Nazira J. Albargothy et al.
ACTA NEUROPATHOLOGICA (2018)
General Anesthesia Inhibits the Activity of the Glymphatic System
Clement Gakuba et al.
THERANOSTICS (2018)
A new era for understanding amyloid structures and disease
Matthew G. Iadanza et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Clearance systems in the brain-implications for Alzheimer disease
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2015)
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Jeffrey J. Iliff et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease
Jinghui Dong et al.
NEUROPHARMACOLOGY (2010)
Plasticity of amyloid fibrils
Ronald Wetzel et al.
BIOCHEMISTRY (2007)
The cerebral beta-amyloid angiopathies: Hereditary and sporadic
SX Zhang-Nunes et al.
BRAIN PATHOLOGY (2006)
Alzheimer disease and cerebrovascular pathology: an update
KA Jellinger
JOURNAL OF NEURAL TRANSMISSION (2002)
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
HF Dovey et al.
JOURNAL OF NEUROCHEMISTRY (2001)